Wells Fargo Initiates Coverage On Pharvaris with Overweight Rating, Announces Price Target of $55

Benzinga Newsdesk www.benzinga.com Neutral 50.6%

Neg 0% Neu 50.6% Pos 0%

Wells Fargo analyst Yanan Zhu initiates coverage on Pharvaris (NASDAQ:PHVS) with a Overweight rating and announces Price Target of $55.